| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | JQ12 | GDSC1000 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |